Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.15B |
| 2 |
Tesla
TSLA
|
+$1.26B |
| 3 |
Vanguard FTSE Europe ETF
VGK
|
+$610M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$482M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$461M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$667M |
| 2 |
iShares Floating Rate Bond ETF
FLOT
|
+$652M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 4 |
Meta Platforms (Facebook)
META
|
+$583M |
| 5 |
iShares MSCI United Kingdom ETF
EWU
|
+$507M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.96% |
| 2 | Consumer Discretionary | 3.1% |
| 3 | Financials | 1.5% |
| 4 | Healthcare | 1.15% |
| 5 | Communication Services | 1.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7601
CarParts.com
PRTS
$54.7M
| $202K | ﹤0.01% |
4,742
+1,705
| +56% | +$76.2K |
|
7602
TETRA Technologies
TTI
$1.26B
| $201K | ﹤0.01% |
59,597
-33,410
| -36% | -$96.6K |
|
7603
PUT
Trimble
TRMB
$13.9B
| $201K | ﹤0.01% |
+3,800
| New | +$186K |
|
|
CBL
7604
CBL Properties
CBL
$1.75B
| $201K | ﹤0.01% |
+9,124
| New | +$214K |
|
7605
VirTra
VTSI
$34.5M
| $201K | ﹤0.01% |
+26,406
| New | +$176K |
|
7606
CALL
Smith & Wesson
SWBI
$637M
| $201K | ﹤0.01% |
15,400
-4,400
| -22% | -$53.6K |
|
7607
PUT
Artisan Partners
APAM
$3.02B
| $200K | ﹤0.01% |
5,100
-22,600
| -82% | -$780K |
|
7608
Medallion Financial
MFIN
$250M
| $200K | ﹤0.01% |
25,329
-42,212
| -62% | -$289K |
|
7609
CALL
Playtika
PLTK
$1.12B
| $200K | ﹤0.01% |
17,200
-69,600
| -80% | -$754K |
|
|
TSE
7610
CALL
DELISTED
Trinseo
TSE
| $199K | ﹤0.01% |
+15,700
| New | +$254K |
|
|
TIO
7611
CALL
DELISTED
Tingo Group, Inc. Common Stock
TIO
| $199K | ﹤0.01% |
+164,300
| New | +$370K |
|
|
CNH
7612
CALL
CNH Industrial
CNH
$17.5B
| $199K | ﹤0.01% |
13,800
-250,900
| -95% | -$3.52M |
|
7613
PDS Biotechnology
PDSB
$43.4M
| $198K | ﹤0.01% |
39,422
-84,514
| -68% | -$553K |
|
|
MYND
7614
Mynd.ai
MYND
$19.3M
| $198K | ﹤0.01% |
26,338
-2,562
| -9% | -$19.1K |
|
7615
Artivion
AORT
$1.32B
| $197K | ﹤0.01% |
11,485
-14,246
| -55% | -$210K |
|
7616
Lyell Immunopharma
LYEL
$360M
| $197K | ﹤0.01% |
3,104
-6,774
| -69% | -$375K |
|
|
CIM
7617
CALL
Chimera Investment
CIM
$1B
| $197K | ﹤0.01% |
11,400
+2,000
| +21% | +$31.8K |
|
7618
PUT
ADMA Biologics
ADMA
$2.22B
| $197K | ﹤0.01% |
53,400
+1,200
| +2% | +$4.45K |
|
|
FPI
7619
CALL
Farmland Partners
FPI
$432M
| $197K | ﹤0.01% |
16,100
+5,600
| +53% | +$62.7K |
|
|
GOGL
7620
CALL
DELISTED
Golden Ocean Group
GOGL
| $196K | ﹤0.01% |
25,900
-29,300
| -53% | -$244K |
|
7621
CALL
Clarivate
CLVT
$1.16B
| $195K | ﹤0.01% |
20,500
+2,000
| +11% | +$17K |
|
|
GFOF
7622
DELISTED
Grayscale Future of Finance ETF
GFOF
| $195K | ﹤0.01% |
+14,749
| New | +$167K |
|
7623
CALL
GoodRx Holdings
GDRX
$1.26B
| $195K | ﹤0.01% |
35,300
+19,000
| +117% | +$102K |
|
|
STER
7624
DELISTED
Sterling Check Corp. Common Stock
STER
| $194K | ﹤0.01% |
15,842
+4,968
| +46% | +$59.5K |
|
|
CHNA
7625
DELISTED
Loncar China BioPharma ETF
CHNA
| $194K | ﹤0.01% |
+11,978
| New | +$208K |
|
Similar funds
Jane Street's Q2 2023 Portfolio in Review
As of Q2 2023, Jane Street held 10,215 positions worth $297B, up 22% from $244B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Jane Street deployed $26.9B of net new capital in Q2 2023, opening 1,302 new positions and adding to 3,894 existing holdings. Its largest new stake was Kenvue: 10,291,011 shares worth $272M.
By sector, the portfolio is most concentrated in Technology at 4% of assets, up from 2.5% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $667M trimmed.
- Jane Street's largest Q2 2023 buy was Kenvue: 10,291,011 shares worth $272M.
- Jane Street added most to Apple in Q2 2023, an estimated $2.15B increase.
- Jane Street's biggest Q2 2023 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $667M.
- Jane Street fully exited JPMorgan BetaBuilders Europe ETF in Q2 2023, selling an estimated $325M.
- Jane Street's ten largest holdings make up 36% of its $297B portfolio in Q2 2023.
- Jane Street opened 1,302 new positions and closed 1,631 in Q2 2023.
- Jane Street's portfolio value rose 22% quarter-over-quarter to $297B.
Based on Jane Street's 13F filing for Q2 2023, filed 14 Aug 2023.